Pharma & Healthcare
Global Direct Oral Anticoagulant Market Research Report 2024
- Jan 29, 24
- ID: 49703
- Pages: 77
- Figures: 186
- Views: 21
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
The global Direct Oral Anticoagulant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Direct Oral Anticoagulant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Direct Oral Anticoagulant.
Report Scope
The Direct Oral Anticoagulant market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Direct Oral Anticoagulant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Direct Oral Anticoagulant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Meyers Squibb Co
Pfizer Inc.
Boehringer Ingelheim Pharmaceuticals, Inc
Janssen Pharmaceuticals, Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd
Pab Organics Private Limited
Daiichi Sankyo Company, Limited
Segment by Type
Apixaban
Dabigatran
Rivaroxaban
Edoxaban
Segment by Application
Hospitals Pharmacies
Drug Stores
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Direct Oral Anticoagulant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Direct Oral Anticoagulant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Direct Oral Anticoagulant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Direct Oral Anticoagulant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Direct Oral Anticoagulant.
Report Scope
The Direct Oral Anticoagulant market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Direct Oral Anticoagulant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Direct Oral Anticoagulant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Meyers Squibb Co
Pfizer Inc.
Boehringer Ingelheim Pharmaceuticals, Inc
Janssen Pharmaceuticals, Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd
Pab Organics Private Limited
Daiichi Sankyo Company, Limited
Segment by Type
Apixaban
Dabigatran
Rivaroxaban
Edoxaban
Segment by Application
Hospitals Pharmacies
Drug Stores
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Direct Oral Anticoagulant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Direct Oral Anticoagulant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Direct Oral Anticoagulant Market Overview
1.1 Product Overview and Scope of Direct Oral Anticoagulant
1.2 Direct Oral Anticoagulant Segment by Type
1.2.1 Global Direct Oral Anticoagulant Market Value Comparison by Type (2024-2030)
1.2.2 Apixaban
1.2.3 Dabigatran
1.2.4 Rivaroxaban
1.2.5 Edoxaban
1.3 Direct Oral Anticoagulant Segment by Application
1.3.1 Global Direct Oral Anticoagulant Market Value by Application: (2024-2030)
1.3.2 Hospitals Pharmacies
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Global Direct Oral Anticoagulant Market Size Estimates and Forecasts
1.4.1 Global Direct Oral Anticoagulant Revenue 2019-2030
1.4.2 Global Direct Oral Anticoagulant Sales 2019-2030
1.4.3 Global Direct Oral Anticoagulant Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Direct Oral Anticoagulant Market Competition by Manufacturers
2.1 Global Direct Oral Anticoagulant Sales Market Share by Manufacturers (2019-2024)
2.2 Global Direct Oral Anticoagulant Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Direct Oral Anticoagulant Average Price by Manufacturers (2019-2024)
2.4 Global Direct Oral Anticoagulant Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Direct Oral Anticoagulant, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Direct Oral Anticoagulant, Product Type & Application
2.7 Direct Oral Anticoagulant Market Competitive Situation and Trends
2.7.1 Direct Oral Anticoagulant Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Direct Oral Anticoagulant Players Market Share by Revenue
2.7.3 Global Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Direct Oral Anticoagulant Retrospective Market Scenario by Region
3.1 Global Direct Oral Anticoagulant Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Direct Oral Anticoagulant Global Direct Oral Anticoagulant Sales by Region: 2019-2030
3.2.1 Global Direct Oral Anticoagulant Sales by Region: 2019-2024
3.2.2 Global Direct Oral Anticoagulant Sales by Region: 2025-2030
3.3 Global Direct Oral Anticoagulant Global Direct Oral Anticoagulant Revenue by Region: 2019-2030
3.3.1 Global Direct Oral Anticoagulant Revenue by Region: 2019-2024
3.3.2 Global Direct Oral Anticoagulant Revenue by Region: 2025-2030
3.4 North America Direct Oral Anticoagulant Market Facts & Figures by Country
3.4.1 North America Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Direct Oral Anticoagulant Sales by Country (2019-2030)
3.4.3 North America Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Direct Oral Anticoagulant Market Facts & Figures by Country
3.5.1 Europe Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Direct Oral Anticoagulant Sales by Country (2019-2030)
3.5.3 Europe Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Direct Oral Anticoagulant Market Facts & Figures by Country
3.6.1 Asia Pacific Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Direct Oral Anticoagulant Sales by Country (2019-2030)
3.6.3 Asia Pacific Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Direct Oral Anticoagulant Market Facts & Figures by Country
3.7.1 Latin America Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Direct Oral Anticoagulant Sales by Country (2019-2030)
3.7.3 Latin America Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Direct Oral Anticoagulant Market Facts & Figures by Country
3.8.1 Middle East and Africa Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Direct Oral Anticoagulant Sales by Country (2019-2030)
3.8.3 Middle East and Africa Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Direct Oral Anticoagulant Sales by Type (2019-2030)
4.1.1 Global Direct Oral Anticoagulant Sales by Type (2019-2024)
4.1.2 Global Direct Oral Anticoagulant Sales by Type (2025-2030)
4.1.3 Global Direct Oral Anticoagulant Sales Market Share by Type (2019-2030)
4.2 Global Direct Oral Anticoagulant Revenue by Type (2019-2030)
4.2.1 Global Direct Oral Anticoagulant Revenue by Type (2019-2024)
4.2.2 Global Direct Oral Anticoagulant Revenue by Type (2025-2030)
4.2.3 Global Direct Oral Anticoagulant Revenue Market Share by Type (2019-2030)
4.3 Global Direct Oral Anticoagulant Price by Type (2019-2030)
5 Segment by Application
5.1 Global Direct Oral Anticoagulant Sales by Application (2019-2030)
5.1.1 Global Direct Oral Anticoagulant Sales by Application (2019-2024)
5.1.2 Global Direct Oral Anticoagulant Sales by Application (2025-2030)
5.1.3 Global Direct Oral Anticoagulant Sales Market Share by Application (2019-2030)
5.2 Global Direct Oral Anticoagulant Revenue by Application (2019-2030)
5.2.1 Global Direct Oral Anticoagulant Revenue by Application (2019-2024)
5.2.2 Global Direct Oral Anticoagulant Revenue by Application (2025-2030)
5.2.3 Global Direct Oral Anticoagulant Revenue Market Share by Application (2019-2030)
5.3 Global Direct Oral Anticoagulant Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol-Meyers Squibb Co
6.1.1 Bristol-Meyers Squibb Co Corporation Information
6.1.2 Bristol-Meyers Squibb Co Description and Business Overview
6.1.3 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product Portfolio
6.1.5 Bristol-Meyers Squibb Co Recent Developments/Updates
6.2 Pfizer Inc.
6.2.1 Pfizer Inc. Corporation Information
6.2.2 Pfizer Inc. Description and Business Overview
6.2.3 Pfizer Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Inc. Direct Oral Anticoagulant Product Portfolio
6.2.5 Pfizer Inc. Recent Developments/Updates
6.3 Boehringer Ingelheim Pharmaceuticals, Inc
6.3.1 Boehringer Ingelheim Pharmaceuticals, Inc Corporation Information
6.3.2 Boehringer Ingelheim Pharmaceuticals, Inc Description and Business Overview
6.3.3 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product Portfolio
6.3.5 Boehringer Ingelheim Pharmaceuticals, Inc Recent Developments/Updates
6.4 Janssen Pharmaceuticals, Inc.
6.4.1 Janssen Pharmaceuticals, Inc. Corporation Information
6.4.2 Janssen Pharmaceuticals, Inc. Description and Business Overview
6.4.3 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product Portfolio
6.4.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
6.5 Bayer AG
6.5.1 Bayer AG Corporation Information
6.5.2 Bayer AG Description and Business Overview
6.5.3 Bayer AG Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer AG Direct Oral Anticoagulant Product Portfolio
6.5.5 Bayer AG Recent Developments/Updates
6.6 Teva Pharmaceutical Industries Ltd
6.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product Portfolio
6.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.7 Pab Organics Private Limited
6.6.1 Pab Organics Private Limited Corporation Information
6.6.2 Pab Organics Private Limited Description and Business Overview
6.6.3 Pab Organics Private Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pab Organics Private Limited Direct Oral Anticoagulant Product Portfolio
6.7.5 Pab Organics Private Limited Recent Developments/Updates
6.8 Daiichi Sankyo Company, Limited
6.8.1 Daiichi Sankyo Company, Limited Corporation Information
6.8.2 Daiichi Sankyo Company, Limited Description and Business Overview
6.8.3 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product Portfolio
6.8.5 Daiichi Sankyo Company, Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Direct Oral Anticoagulant Industry Chain Analysis
7.2 Direct Oral Anticoagulant Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Direct Oral Anticoagulant Production Mode & Process
7.4 Direct Oral Anticoagulant Sales and Marketing
7.4.1 Direct Oral Anticoagulant Sales Channels
7.4.2 Direct Oral Anticoagulant Distributors
7.5 Direct Oral Anticoagulant Customers
8 Direct Oral Anticoagulant Market Dynamics
8.1 Direct Oral Anticoagulant Industry Trends
8.2 Direct Oral Anticoagulant Market Drivers
8.3 Direct Oral Anticoagulant Market Challenges
8.4 Direct Oral Anticoagulant Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Direct Oral Anticoagulant
1.2 Direct Oral Anticoagulant Segment by Type
1.2.1 Global Direct Oral Anticoagulant Market Value Comparison by Type (2024-2030)
1.2.2 Apixaban
1.2.3 Dabigatran
1.2.4 Rivaroxaban
1.2.5 Edoxaban
1.3 Direct Oral Anticoagulant Segment by Application
1.3.1 Global Direct Oral Anticoagulant Market Value by Application: (2024-2030)
1.3.2 Hospitals Pharmacies
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Global Direct Oral Anticoagulant Market Size Estimates and Forecasts
1.4.1 Global Direct Oral Anticoagulant Revenue 2019-2030
1.4.2 Global Direct Oral Anticoagulant Sales 2019-2030
1.4.3 Global Direct Oral Anticoagulant Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Direct Oral Anticoagulant Market Competition by Manufacturers
2.1 Global Direct Oral Anticoagulant Sales Market Share by Manufacturers (2019-2024)
2.2 Global Direct Oral Anticoagulant Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Direct Oral Anticoagulant Average Price by Manufacturers (2019-2024)
2.4 Global Direct Oral Anticoagulant Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Direct Oral Anticoagulant, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Direct Oral Anticoagulant, Product Type & Application
2.7 Direct Oral Anticoagulant Market Competitive Situation and Trends
2.7.1 Direct Oral Anticoagulant Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Direct Oral Anticoagulant Players Market Share by Revenue
2.7.3 Global Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Direct Oral Anticoagulant Retrospective Market Scenario by Region
3.1 Global Direct Oral Anticoagulant Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Direct Oral Anticoagulant Global Direct Oral Anticoagulant Sales by Region: 2019-2030
3.2.1 Global Direct Oral Anticoagulant Sales by Region: 2019-2024
3.2.2 Global Direct Oral Anticoagulant Sales by Region: 2025-2030
3.3 Global Direct Oral Anticoagulant Global Direct Oral Anticoagulant Revenue by Region: 2019-2030
3.3.1 Global Direct Oral Anticoagulant Revenue by Region: 2019-2024
3.3.2 Global Direct Oral Anticoagulant Revenue by Region: 2025-2030
3.4 North America Direct Oral Anticoagulant Market Facts & Figures by Country
3.4.1 North America Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Direct Oral Anticoagulant Sales by Country (2019-2030)
3.4.3 North America Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Direct Oral Anticoagulant Market Facts & Figures by Country
3.5.1 Europe Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Direct Oral Anticoagulant Sales by Country (2019-2030)
3.5.3 Europe Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Direct Oral Anticoagulant Market Facts & Figures by Country
3.6.1 Asia Pacific Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Direct Oral Anticoagulant Sales by Country (2019-2030)
3.6.3 Asia Pacific Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Direct Oral Anticoagulant Market Facts & Figures by Country
3.7.1 Latin America Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Direct Oral Anticoagulant Sales by Country (2019-2030)
3.7.3 Latin America Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Direct Oral Anticoagulant Market Facts & Figures by Country
3.8.1 Middle East and Africa Direct Oral Anticoagulant Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Direct Oral Anticoagulant Sales by Country (2019-2030)
3.8.3 Middle East and Africa Direct Oral Anticoagulant Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Direct Oral Anticoagulant Sales by Type (2019-2030)
4.1.1 Global Direct Oral Anticoagulant Sales by Type (2019-2024)
4.1.2 Global Direct Oral Anticoagulant Sales by Type (2025-2030)
4.1.3 Global Direct Oral Anticoagulant Sales Market Share by Type (2019-2030)
4.2 Global Direct Oral Anticoagulant Revenue by Type (2019-2030)
4.2.1 Global Direct Oral Anticoagulant Revenue by Type (2019-2024)
4.2.2 Global Direct Oral Anticoagulant Revenue by Type (2025-2030)
4.2.3 Global Direct Oral Anticoagulant Revenue Market Share by Type (2019-2030)
4.3 Global Direct Oral Anticoagulant Price by Type (2019-2030)
5 Segment by Application
5.1 Global Direct Oral Anticoagulant Sales by Application (2019-2030)
5.1.1 Global Direct Oral Anticoagulant Sales by Application (2019-2024)
5.1.2 Global Direct Oral Anticoagulant Sales by Application (2025-2030)
5.1.3 Global Direct Oral Anticoagulant Sales Market Share by Application (2019-2030)
5.2 Global Direct Oral Anticoagulant Revenue by Application (2019-2030)
5.2.1 Global Direct Oral Anticoagulant Revenue by Application (2019-2024)
5.2.2 Global Direct Oral Anticoagulant Revenue by Application (2025-2030)
5.2.3 Global Direct Oral Anticoagulant Revenue Market Share by Application (2019-2030)
5.3 Global Direct Oral Anticoagulant Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol-Meyers Squibb Co
6.1.1 Bristol-Meyers Squibb Co Corporation Information
6.1.2 Bristol-Meyers Squibb Co Description and Business Overview
6.1.3 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product Portfolio
6.1.5 Bristol-Meyers Squibb Co Recent Developments/Updates
6.2 Pfizer Inc.
6.2.1 Pfizer Inc. Corporation Information
6.2.2 Pfizer Inc. Description and Business Overview
6.2.3 Pfizer Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Inc. Direct Oral Anticoagulant Product Portfolio
6.2.5 Pfizer Inc. Recent Developments/Updates
6.3 Boehringer Ingelheim Pharmaceuticals, Inc
6.3.1 Boehringer Ingelheim Pharmaceuticals, Inc Corporation Information
6.3.2 Boehringer Ingelheim Pharmaceuticals, Inc Description and Business Overview
6.3.3 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product Portfolio
6.3.5 Boehringer Ingelheim Pharmaceuticals, Inc Recent Developments/Updates
6.4 Janssen Pharmaceuticals, Inc.
6.4.1 Janssen Pharmaceuticals, Inc. Corporation Information
6.4.2 Janssen Pharmaceuticals, Inc. Description and Business Overview
6.4.3 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product Portfolio
6.4.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
6.5 Bayer AG
6.5.1 Bayer AG Corporation Information
6.5.2 Bayer AG Description and Business Overview
6.5.3 Bayer AG Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer AG Direct Oral Anticoagulant Product Portfolio
6.5.5 Bayer AG Recent Developments/Updates
6.6 Teva Pharmaceutical Industries Ltd
6.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product Portfolio
6.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.7 Pab Organics Private Limited
6.6.1 Pab Organics Private Limited Corporation Information
6.6.2 Pab Organics Private Limited Description and Business Overview
6.6.3 Pab Organics Private Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pab Organics Private Limited Direct Oral Anticoagulant Product Portfolio
6.7.5 Pab Organics Private Limited Recent Developments/Updates
6.8 Daiichi Sankyo Company, Limited
6.8.1 Daiichi Sankyo Company, Limited Corporation Information
6.8.2 Daiichi Sankyo Company, Limited Description and Business Overview
6.8.3 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product Portfolio
6.8.5 Daiichi Sankyo Company, Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Direct Oral Anticoagulant Industry Chain Analysis
7.2 Direct Oral Anticoagulant Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Direct Oral Anticoagulant Production Mode & Process
7.4 Direct Oral Anticoagulant Sales and Marketing
7.4.1 Direct Oral Anticoagulant Sales Channels
7.4.2 Direct Oral Anticoagulant Distributors
7.5 Direct Oral Anticoagulant Customers
8 Direct Oral Anticoagulant Market Dynamics
8.1 Direct Oral Anticoagulant Industry Trends
8.2 Direct Oral Anticoagulant Market Drivers
8.3 Direct Oral Anticoagulant Market Challenges
8.4 Direct Oral Anticoagulant Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Direct Oral Anticoagulant Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Direct Oral Anticoagulant Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Direct Oral Anticoagulant Market Competitive Situation by Manufacturers in 2023
Table 4. Global Direct Oral Anticoagulant Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Direct Oral Anticoagulant Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Direct Oral Anticoagulant Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Direct Oral Anticoagulant Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Direct Oral Anticoagulant Average Price (USD/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Direct Oral Anticoagulant, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Direct Oral Anticoagulant, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Direct Oral Anticoagulant, Product Type & Application
Table 12. Global Key Manufacturers of Direct Oral Anticoagulant, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Direct Oral Anticoagulant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Direct Oral Anticoagulant as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Direct Oral Anticoagulant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Direct Oral Anticoagulant Sales by Region (2019-2024) & (MT)
Table 18. Global Direct Oral Anticoagulant Sales Market Share by Region (2019-2024)
Table 19. Global Direct Oral Anticoagulant Sales by Region (2025-2030) & (MT)
Table 20. Global Direct Oral Anticoagulant Sales Market Share by Region (2025-2030)
Table 21. Global Direct Oral Anticoagulant Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Direct Oral Anticoagulant Revenue Market Share by Region (2019-2024)
Table 23. Global Direct Oral Anticoagulant Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Direct Oral Anticoagulant Revenue Market Share by Region (2025-2030)
Table 25. North America Direct Oral Anticoagulant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Direct Oral Anticoagulant Sales by Country (2019-2024) & (MT)
Table 27. North America Direct Oral Anticoagulant Sales by Country (2025-2030) & (MT)
Table 28. North America Direct Oral Anticoagulant Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Direct Oral Anticoagulant Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Direct Oral Anticoagulant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Direct Oral Anticoagulant Sales by Country (2019-2024) & (MT)
Table 32. Europe Direct Oral Anticoagulant Sales by Country (2025-2030) & (MT)
Table 33. Europe Direct Oral Anticoagulant Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Direct Oral Anticoagulant Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Direct Oral Anticoagulant Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Direct Oral Anticoagulant Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Direct Oral Anticoagulant Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Direct Oral Anticoagulant Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Direct Oral Anticoagulant Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Direct Oral Anticoagulant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Direct Oral Anticoagulant Sales by Country (2019-2024) & (MT)
Table 42. Latin America Direct Oral Anticoagulant Sales by Country (2025-2030) & (MT)
Table 43. Latin America Direct Oral Anticoagulant Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Direct Oral Anticoagulant Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Direct Oral Anticoagulant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Direct Oral Anticoagulant Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Direct Oral Anticoagulant Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Direct Oral Anticoagulant Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Direct Oral Anticoagulant Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Direct Oral Anticoagulant Sales (MT) by Type (2019-2024)
Table 51. Global Direct Oral Anticoagulant Sales (MT) by Type (2025-2030)
Table 52. Global Direct Oral Anticoagulant Sales Market Share by Type (2019-2024)
Table 53. Global Direct Oral Anticoagulant Sales Market Share by Type (2025-2030)
Table 54. Global Direct Oral Anticoagulant Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Direct Oral Anticoagulant Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Direct Oral Anticoagulant Revenue Market Share by Type (2019-2024)
Table 57. Global Direct Oral Anticoagulant Revenue Market Share by Type (2025-2030)
Table 58. Global Direct Oral Anticoagulant Price (USD/Kg) by Type (2019-2024)
Table 59. Global Direct Oral Anticoagulant Price (USD/Kg) by Type (2025-2030)
Table 60. Global Direct Oral Anticoagulant Sales (MT) by Application (2019-2024)
Table 61. Global Direct Oral Anticoagulant Sales (MT) by Application (2025-2030)
Table 62. Global Direct Oral Anticoagulant Sales Market Share by Application (2019-2024)
Table 63. Global Direct Oral Anticoagulant Sales Market Share by Application (2025-2030)
Table 64. Global Direct Oral Anticoagulant Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Direct Oral Anticoagulant Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Direct Oral Anticoagulant Revenue Market Share by Application (2019-2024)
Table 67. Global Direct Oral Anticoagulant Revenue Market Share by Application (2025-2030)
Table 68. Global Direct Oral Anticoagulant Price (USD/Kg) by Application (2019-2024)
Table 69. Global Direct Oral Anticoagulant Price (USD/Kg) by Application (2025-2030)
Table 70. Bristol-Meyers Squibb Co Corporation Information
Table 71. Bristol-Meyers Squibb Co Description and Business Overview
Table 72. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 73. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product
Table 74. Bristol-Meyers Squibb Co Recent Developments/Updates
Table 75. Pfizer Inc. Corporation Information
Table 76. Pfizer Inc. Description and Business Overview
Table 77. Pfizer Inc. Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 78. Pfizer Inc. Direct Oral Anticoagulant Product
Table 79. Pfizer Inc. Recent Developments/Updates
Table 80. Boehringer Ingelheim Pharmaceuticals, Inc Corporation Information
Table 81. Boehringer Ingelheim Pharmaceuticals, Inc Description and Business Overview
Table 82. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product
Table 84. Boehringer Ingelheim Pharmaceuticals, Inc Recent Developments/Updates
Table 85. Janssen Pharmaceuticals, Inc. Corporation Information
Table 86. Janssen Pharmaceuticals, Inc. Description and Business Overview
Table 87. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 88. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product
Table 89. Janssen Pharmaceuticals, Inc. Recent Developments/Updates
Table 90. Bayer AG Corporation Information
Table 91. Bayer AG Description and Business Overview
Table 92. Bayer AG Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 93. Bayer AG Direct Oral Anticoagulant Product
Table 94. Bayer AG Recent Developments/Updates
Table 95. Teva Pharmaceutical Industries Ltd Corporation Information
Table 96. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 97. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 98. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product
Table 99. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 100. Pab Organics Private Limited Corporation Information
Table 101. Pab Organics Private Limited Description and Business Overview
Table 102. Pab Organics Private Limited Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 103. Pab Organics Private Limited Direct Oral Anticoagulant Product
Table 104. Pab Organics Private Limited Recent Developments/Updates
Table 105. Daiichi Sankyo Company, Limited Corporation Information
Table 106. Daiichi Sankyo Company, Limited Description and Business Overview
Table 107. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 108. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product
Table 109. Daiichi Sankyo Company, Limited Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Direct Oral Anticoagulant Distributors List
Table 113. Direct Oral Anticoagulant Customers List
Table 114. Direct Oral Anticoagulant Market Trends
Table 115. Direct Oral Anticoagulant Market Drivers
Table 116. Direct Oral Anticoagulant Market Challenges
Table 117. Direct Oral Anticoagulant Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Direct Oral Anticoagulant
Figure 2. Global Direct Oral Anticoagulant Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Direct Oral Anticoagulant Market Share by Type in 2023 & 2030
Figure 4. Apixaban Product Picture
Figure 5. Dabigatran Product Picture
Figure 6. Rivaroxaban Product Picture
Figure 7. Edoxaban Product Picture
Figure 8. Global Direct Oral Anticoagulant Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Direct Oral Anticoagulant Market Share by Application in 2023 & 2030
Figure 10. Hospitals Pharmacies
Figure 11. Drug Stores
Figure 12. Online Pharmacies
Figure 13. Global Direct Oral Anticoagulant Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Direct Oral Anticoagulant Market Size (2019-2030) & (US$ Million)
Figure 15. Global Direct Oral Anticoagulant Sales (2019-2030) & (MT)
Figure 16. Global Direct Oral Anticoagulant Average Price (USD/Kg) & (2019-2030)
Figure 17. Direct Oral Anticoagulant Report Years Considered
Figure 18. Direct Oral Anticoagulant Sales Share by Manufacturers in 2023
Figure 19. Global Direct Oral Anticoagulant Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Direct Oral Anticoagulant Players: Market Share by Revenue in 2023
Figure 21. Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Direct Oral Anticoagulant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Direct Oral Anticoagulant Sales Market Share by Country (2019-2030)
Figure 24. North America Direct Oral Anticoagulant Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Direct Oral Anticoagulant Sales Market Share by Country (2019-2030)
Figure 28. Europe Direct Oral Anticoagulant Revenue Market Share by Country (2019-2030)
Figure 29. Germany Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Direct Oral Anticoagulant Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Direct Oral Anticoagulant Revenue Market Share by Region (2019-2030)
Figure 36. China Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Direct Oral Anticoagulant Sales Market Share by Country (2019-2030)
Figure 47. Latin America Direct Oral Anticoagulant Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Direct Oral Anticoagulant Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Direct Oral Anticoagulant Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Direct Oral Anticoagulant by Type (2019-2030)
Figure 57. Global Revenue Market Share of Direct Oral Anticoagulant by Type (2019-2030)
Figure 58. Global Direct Oral Anticoagulant Price (USD/Kg) by Type (2019-2030)
Figure 59. Global Sales Market Share of Direct Oral Anticoagulant by Application (2019-2030)
Figure 60. Global Revenue Market Share of Direct Oral Anticoagulant by Application (2019-2030)
Figure 61. Global Direct Oral Anticoagulant Price (USD/Kg) by Application (2019-2030)
Figure 62. Direct Oral Anticoagulant Value Chain
Figure 63. Direct Oral Anticoagulant Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Direct Oral Anticoagulant Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Direct Oral Anticoagulant Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Direct Oral Anticoagulant Market Competitive Situation by Manufacturers in 2023
Table 4. Global Direct Oral Anticoagulant Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Direct Oral Anticoagulant Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Direct Oral Anticoagulant Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Direct Oral Anticoagulant Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Direct Oral Anticoagulant Average Price (USD/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Direct Oral Anticoagulant, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Direct Oral Anticoagulant, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Direct Oral Anticoagulant, Product Type & Application
Table 12. Global Key Manufacturers of Direct Oral Anticoagulant, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Direct Oral Anticoagulant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Direct Oral Anticoagulant as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Direct Oral Anticoagulant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Direct Oral Anticoagulant Sales by Region (2019-2024) & (MT)
Table 18. Global Direct Oral Anticoagulant Sales Market Share by Region (2019-2024)
Table 19. Global Direct Oral Anticoagulant Sales by Region (2025-2030) & (MT)
Table 20. Global Direct Oral Anticoagulant Sales Market Share by Region (2025-2030)
Table 21. Global Direct Oral Anticoagulant Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Direct Oral Anticoagulant Revenue Market Share by Region (2019-2024)
Table 23. Global Direct Oral Anticoagulant Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Direct Oral Anticoagulant Revenue Market Share by Region (2025-2030)
Table 25. North America Direct Oral Anticoagulant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Direct Oral Anticoagulant Sales by Country (2019-2024) & (MT)
Table 27. North America Direct Oral Anticoagulant Sales by Country (2025-2030) & (MT)
Table 28. North America Direct Oral Anticoagulant Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Direct Oral Anticoagulant Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Direct Oral Anticoagulant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Direct Oral Anticoagulant Sales by Country (2019-2024) & (MT)
Table 32. Europe Direct Oral Anticoagulant Sales by Country (2025-2030) & (MT)
Table 33. Europe Direct Oral Anticoagulant Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Direct Oral Anticoagulant Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Direct Oral Anticoagulant Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Direct Oral Anticoagulant Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Direct Oral Anticoagulant Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Direct Oral Anticoagulant Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Direct Oral Anticoagulant Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Direct Oral Anticoagulant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Direct Oral Anticoagulant Sales by Country (2019-2024) & (MT)
Table 42. Latin America Direct Oral Anticoagulant Sales by Country (2025-2030) & (MT)
Table 43. Latin America Direct Oral Anticoagulant Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Direct Oral Anticoagulant Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Direct Oral Anticoagulant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Direct Oral Anticoagulant Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Direct Oral Anticoagulant Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Direct Oral Anticoagulant Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Direct Oral Anticoagulant Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Direct Oral Anticoagulant Sales (MT) by Type (2019-2024)
Table 51. Global Direct Oral Anticoagulant Sales (MT) by Type (2025-2030)
Table 52. Global Direct Oral Anticoagulant Sales Market Share by Type (2019-2024)
Table 53. Global Direct Oral Anticoagulant Sales Market Share by Type (2025-2030)
Table 54. Global Direct Oral Anticoagulant Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Direct Oral Anticoagulant Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Direct Oral Anticoagulant Revenue Market Share by Type (2019-2024)
Table 57. Global Direct Oral Anticoagulant Revenue Market Share by Type (2025-2030)
Table 58. Global Direct Oral Anticoagulant Price (USD/Kg) by Type (2019-2024)
Table 59. Global Direct Oral Anticoagulant Price (USD/Kg) by Type (2025-2030)
Table 60. Global Direct Oral Anticoagulant Sales (MT) by Application (2019-2024)
Table 61. Global Direct Oral Anticoagulant Sales (MT) by Application (2025-2030)
Table 62. Global Direct Oral Anticoagulant Sales Market Share by Application (2019-2024)
Table 63. Global Direct Oral Anticoagulant Sales Market Share by Application (2025-2030)
Table 64. Global Direct Oral Anticoagulant Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Direct Oral Anticoagulant Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Direct Oral Anticoagulant Revenue Market Share by Application (2019-2024)
Table 67. Global Direct Oral Anticoagulant Revenue Market Share by Application (2025-2030)
Table 68. Global Direct Oral Anticoagulant Price (USD/Kg) by Application (2019-2024)
Table 69. Global Direct Oral Anticoagulant Price (USD/Kg) by Application (2025-2030)
Table 70. Bristol-Meyers Squibb Co Corporation Information
Table 71. Bristol-Meyers Squibb Co Description and Business Overview
Table 72. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 73. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product
Table 74. Bristol-Meyers Squibb Co Recent Developments/Updates
Table 75. Pfizer Inc. Corporation Information
Table 76. Pfizer Inc. Description and Business Overview
Table 77. Pfizer Inc. Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 78. Pfizer Inc. Direct Oral Anticoagulant Product
Table 79. Pfizer Inc. Recent Developments/Updates
Table 80. Boehringer Ingelheim Pharmaceuticals, Inc Corporation Information
Table 81. Boehringer Ingelheim Pharmaceuticals, Inc Description and Business Overview
Table 82. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product
Table 84. Boehringer Ingelheim Pharmaceuticals, Inc Recent Developments/Updates
Table 85. Janssen Pharmaceuticals, Inc. Corporation Information
Table 86. Janssen Pharmaceuticals, Inc. Description and Business Overview
Table 87. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 88. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product
Table 89. Janssen Pharmaceuticals, Inc. Recent Developments/Updates
Table 90. Bayer AG Corporation Information
Table 91. Bayer AG Description and Business Overview
Table 92. Bayer AG Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 93. Bayer AG Direct Oral Anticoagulant Product
Table 94. Bayer AG Recent Developments/Updates
Table 95. Teva Pharmaceutical Industries Ltd Corporation Information
Table 96. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 97. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 98. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product
Table 99. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 100. Pab Organics Private Limited Corporation Information
Table 101. Pab Organics Private Limited Description and Business Overview
Table 102. Pab Organics Private Limited Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 103. Pab Organics Private Limited Direct Oral Anticoagulant Product
Table 104. Pab Organics Private Limited Recent Developments/Updates
Table 105. Daiichi Sankyo Company, Limited Corporation Information
Table 106. Daiichi Sankyo Company, Limited Description and Business Overview
Table 107. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 108. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product
Table 109. Daiichi Sankyo Company, Limited Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Direct Oral Anticoagulant Distributors List
Table 113. Direct Oral Anticoagulant Customers List
Table 114. Direct Oral Anticoagulant Market Trends
Table 115. Direct Oral Anticoagulant Market Drivers
Table 116. Direct Oral Anticoagulant Market Challenges
Table 117. Direct Oral Anticoagulant Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Direct Oral Anticoagulant
Figure 2. Global Direct Oral Anticoagulant Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Direct Oral Anticoagulant Market Share by Type in 2023 & 2030
Figure 4. Apixaban Product Picture
Figure 5. Dabigatran Product Picture
Figure 6. Rivaroxaban Product Picture
Figure 7. Edoxaban Product Picture
Figure 8. Global Direct Oral Anticoagulant Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Direct Oral Anticoagulant Market Share by Application in 2023 & 2030
Figure 10. Hospitals Pharmacies
Figure 11. Drug Stores
Figure 12. Online Pharmacies
Figure 13. Global Direct Oral Anticoagulant Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Direct Oral Anticoagulant Market Size (2019-2030) & (US$ Million)
Figure 15. Global Direct Oral Anticoagulant Sales (2019-2030) & (MT)
Figure 16. Global Direct Oral Anticoagulant Average Price (USD/Kg) & (2019-2030)
Figure 17. Direct Oral Anticoagulant Report Years Considered
Figure 18. Direct Oral Anticoagulant Sales Share by Manufacturers in 2023
Figure 19. Global Direct Oral Anticoagulant Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Direct Oral Anticoagulant Players: Market Share by Revenue in 2023
Figure 21. Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Direct Oral Anticoagulant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Direct Oral Anticoagulant Sales Market Share by Country (2019-2030)
Figure 24. North America Direct Oral Anticoagulant Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Direct Oral Anticoagulant Sales Market Share by Country (2019-2030)
Figure 28. Europe Direct Oral Anticoagulant Revenue Market Share by Country (2019-2030)
Figure 29. Germany Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Direct Oral Anticoagulant Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Direct Oral Anticoagulant Revenue Market Share by Region (2019-2030)
Figure 36. China Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Direct Oral Anticoagulant Sales Market Share by Country (2019-2030)
Figure 47. Latin America Direct Oral Anticoagulant Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Direct Oral Anticoagulant Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Direct Oral Anticoagulant Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Direct Oral Anticoagulant Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Direct Oral Anticoagulant by Type (2019-2030)
Figure 57. Global Revenue Market Share of Direct Oral Anticoagulant by Type (2019-2030)
Figure 58. Global Direct Oral Anticoagulant Price (USD/Kg) by Type (2019-2030)
Figure 59. Global Sales Market Share of Direct Oral Anticoagulant by Application (2019-2030)
Figure 60. Global Revenue Market Share of Direct Oral Anticoagulant by Application (2019-2030)
Figure 61. Global Direct Oral Anticoagulant Price (USD/Kg) by Application (2019-2030)
Figure 62. Direct Oral Anticoagulant Value Chain
Figure 63. Direct Oral Anticoagulant Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232